Deca Blend 450 Nandrolone Blend

Deca Blend 450 INJECTION

COMPOSITEON
Each 1ml contains:
Nandrolone Decanoate                USP         150mg
Nandrolone Undecanoate            USP         150mg 
Nandrolone Phenylpropionate     USP         150mg

PHARMACOLOGICAL CLASSIFICATION

Anabolic Steroids

PHARMACOLOGICAL ACTION
Deca Blend is a mix of Nandrolone Decanoate, Nandrolone Undecanoate and Nandrolone Phenylpropionate. After injection, Nandrolone Decanoate is gradually released from the intramuscular depot and subsequently hydrolysed into nandrolone.
Nandrolone Undecanoate is an anabolic steroid which are a group of drugs that are usually synthesized from the male reproduction hormone testosterone , and it can helps to rebuild body tissue, increase body and bone mass and encourage the formation of red blood cells.
Nandrolone phenylpropionate is an anabolic steroid, similar in the mechanism of action to nandrolone decanoate and nandrolone undecanoate. It has been shown to positively control calcium metabolism either to swell bone weight in osteoporosis. It is not recommended to be used in female with dispersed mammary carcinoma due to the regression for a prolonged period of time it causes. Nandrolone phenylpropionate is used by athletes with the scope of gaining muscular mass and strength. It works well if the patient also follows a diet high in proteins and calories. It is a drug that may be obtained without prescription. It is not known whether it causes addiction or not. In order to get better informed about potential risks of therapy with this drug patients are advised to consult a doctor first and get correct prescription of doses and all information related to the therapy with it.

INDICATIONS
As an anabolic steroid.
Certain cases of disseminated breast cancer in women.
Osteoporosis due to androgen deficiency in hypogonadal males.

CONTRA-INDICATIONS
Not intended for use in children.
Known or suspected prostatic carcinoma and mammary carcinoma in the male.
Not intended for use in female patients other than those with disseminated breast cancer.

Contraindicated in nephrosis or the nephrotic phase of nephritis, cardiac and renal failure, hypercalcaemia, oedema, jaundice, liver disease with impaired bilirubin excretion, testicular and hepatic carcinoma.

 

SIDE-EFFECTS AND SPECIAL PRECAUTIONS
Virilisation which appears in sensitive women as hoarseness, acne, hirsutism, and increased libido; in prepubertal boys as an increased frequency of erections and phallic enlargement, and in girls as an increase of pubic hair and clitoral hypertrophy. Hoarseness may be the first symptom of vocal change which may end in a long-lasting, sometimes irreversible deepening of the voice.

Other adverse reactions may include:
Oligospermia and decreased ejaculatory volume;
Suppression of ovarian activity, atrophy of the breasts and endometrial tissue.
Amenorrhoea and inhibition of spermatogenesis.
Water and salt retention.
Premature epiphyseal closure.
If signs of virilisation develop, treatment should be discontinued.
Increase in nitrogen retention and skeletal weight;
Oedema;
Increased vascularity of the skin;
Increased growth of the bone;
Elderly males may become over-stimulated.

STORAGE INSTRUCTIONS
Store at room temperature below 30° C.

Leave a Reply

Your email address will not be published. Required fields are marked *